The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial

Supporters

Support the authors with ResearchCoin

Tip RSC

Journal

The Lancet

Topics

Engineering

Pathology

Medicine

Internal Medicine

Cardiology

Show all topics

DOI

10.1016/s0140-6736(11)60739-3

Other Formats

PDF